Fig. 1 · Structure
Documents & Downloads
Insulin efsitora alfa
Insulin Receptor Agonist
Insulin efsitora alfa is a selective agonist of the insulin receptor (IR) designed to enhance insulin signaling. This fusion protein, which combines human insulin receptor agonists with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2), has a molecular weight of 64.1 kDa. Insulin efsitora alfa exhibits promising biological activity in modulating glucose metabolism and has potential applications in the treatment of diabetes and related metabolic disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 2131038-11-2 |
| Applications | Insulin Receptor Agonist |
| Molecular Weight | 64.1 kDa |
| Synonyms | LY-3209590 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.